Short reportRisk-assessment-based approach to patients exposed to endoscopes contaminated with Pseudomonas spp.
Introduction
Invasive Pseudomonas aeruginosa infection is a rare complication of bronchoscopy, usually resulting from inadequate scope disinfection. The risk of invasive infection, such as pneumonia or bacteraemia, following exposure to a contaminated bronchoscope has been estimated to be between 9% and 25%.1, 2, 3, 4, 5, 6 The risk is likely to vary according to the nature of the scope and the procedure undertaken, with lavage or biopsy of sterile sites considered to be higher risk. The risk is also likely to be dependent on patient comorbidities, such as immunosuppression, critical illness or chronic lung disease. Previous literature has focused on the retrospective recognition of bronchoscopic contamination following an outbreak of P. aeruginosa, by which point it is too late to institute preventative measures for exposed patients. Routine surveillance of endoscope washer-disinfector (EWD) rinse water for the presence of Pseudomonas spp. now enables early detection of exposure. However, good-quality evidence that would inform the prospective management of a cohort of patients exposed to Pseudomonas spp. via bronchoscopy is lacking. Reasoning that the risks of infection were specific to both the scope and the patient, a two-phase risk assessment was adopted following an episode of pseudomonal contamination of an EWD that had processed a family of endoscopes.
Section snippets
Setting
The Southern General Hospital is a 900-bed hospital in Glasgow with tertiary care services for neurology, and undertakes approximately 400 bronchoscopic procedures annually. The majority of bronchoscopic procedures are performed in a dedicated suite, but some are performed in operating theatres or the intensive care unit.
Cleaning and disinfection procedures
Endoscopes are cleaned in accordance with national guidance by trained personnel, and disinfected (peracetic acid) in one of three EWDs (Steris PTX, Steris Corp., Basingstoke,
Results
Initial scope risk stratification identified nine scopes as high risk, all of which were lumened intubation bronchoscopes used for assisting intubation rather than diagnostic procedures. The procedures performed and clinical details of the exposed patients are shown in Table I. The risk assessment was facilitated by the use of the Scantrack scope/patient tracking and traceability system (Scantrack Health Care, Bristol, UK), enabling rapid identification of at-risk patients. All scopes were used
Discussion
Previous evidence suggests that up to 25% of patients exposed to bronchoscopes contaminated with P. aeruginosa develop invasive infection. The wide range of risk estimates in the literature likely reflects the heterogeneity of scopes, procedures and patients involved.1, 2, 3, 4, 5, 6 Invasive pseudomonal infection is associated with poor outcomes, particularly when empirical antimicrobials lack antipseudomonal activity.8 Endoscope reprocessing guidance focuses on preventing cross-infection and
Conflict of interest statement
None declared.
Funding sources
None.
References (10)
- et al.
Unusual implication of biopsy forceps in outbreaks of Pseudomonas aeruginosa infections and pseudoinfections related to bronchoscopy
J Hosp Infect
(2005) - et al.
Nosocomial outbreak of Pseudomonas aeruginosa infections related to a flexible bronchoscope
J Hosp Infect
(2006) Bronchoscopy-related infections and pseudoinfections – New York, 1996 and 1998
Morb Mortal Wkly Rep
(1999)- et al.
An outbreak of Pseudomonas aeruginosa infections associated with flexible bronchoscopes
N Engl J Med
(2003) - et al.
Pseudomonas aeruginosa and Serratia marcescens contamination associated with a manufacturing defect in bronchoscopes
N Engl J Med
(2003)
Cited by (3)
Nosocomial outbreaks caused by Acinetobacter baumannii and Pseudomonas aeruginosa: Results of a systematic review
2018, American Journal of Infection ControlCitation Excerpt :The 2 corresponding main outbreak sources were the use of contaminated water and medical devices. This is plausible because P aeruginosa is considered among the indicator microorganisms for insufficiently reprocessed endoscopes and numerous transmissions and infections have been observed this way.26,27 We did not find a relevant influence of so-called MDR on the outcome of infections by either A baumannii (mortality rates 48% vs 43%) or P aeruginosa (30% vs 25%).
Medical Device-Associated Healthcare Infections: Sterilization and the Potential of Novel Biological Approaches to Ensure Patient Safety
2024, International Journal of Molecular SciencesNosocomial outbreak linked to a flexible gastrointestinal endoscope contaminated with an amikacin-resistant ST17 clone of Pseudomonas aeruginosa
2020, European Journal of Clinical Microbiology and Infectious Diseases